Article info
Clinical and epidemiological research
Extended report
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
- Correspondence to Dr S B Cohen, Metroplex Clinical Research Center, Dallas, Texas, USA; scohen{at}arthdocs.com
Citation
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate
Publication history
- Accepted November 19, 2009
- First published May 3, 2010.
Online issue publication
May 24, 2010
Article Versions
- Previous version (3 May 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl